STOCKSCOPE

NEXTDC (ASX: NXT): A$140 Million Revenue Setback Raises a Bigger Question About AI Infrastructure

Danny Aad

Danny Aad

Technology & Biotechnology Specialist | StockScope

Published:26 Oct 2026
NEXTDC (ASX: NXT): A$140 Million Revenue Setback Raises a Bigger Question About AI Infrastructure

NEXTDC’s (ASX: NXT) shares have fallen sharply after a power supply delay at its Melbourne data centre forced a major downgrade to financial guidance. The setback highlights a risk that could extend beyond one project: even with customers signed up, data centre operators cannot generate revenue from capacity they cannot reliably power and deliver.

The numbers tell a different story

  • Share price: A$5.61 at the 23 October close, down approximately 39% from A$9.18 on 16 October.
  • FY27 revenue: A$475 million to A$500 million, down from A$615 million to A$640 million.
  • Underlying EBITDA: A$245 million to A$265 million, compared with A$385 million to A$410 million previously.
  • Liquidity: A$8.675 billion at 30 September 2026.
  • Capital expenditure: A$4.5 billion to A$5 billion forecast for FY27, down from A$5.25 billion to A$5.75 billion.

The problem is bigger than delayed electricity

The immediate issue is NEXTDC’s M3 Melbourne facility, where electricity network works have been suspended following community opposition and stakeholder concerns. The next increase in grid supply is now expected in FY28, delaying the delivery and billing of contracted capacity.

The affected contracts accounted for approximately A$140 million of revenue and underlying EBITDA in the company's previous FY27 guidance. NEXTDC has excluded their contribution from its revised forecasts while it works through the uncertainty.

That distinction matters. The company has not simply lost a customer order; it faces a delay in converting contracted demand into financial performance, alongside potential contractual obligations and uncertainty over the project's completion costs.

Growth now depends on execution

NEXTDC operates data centres that provide secure space, power and connectivity for cloud providers, businesses and government customers. Demand from cloud computing and artificial intelligence creates a substantial long-term opportunity, but expansion requires enormous upfront spending and reliable electricity infrastructure.

The company is responding by prioritising contracted capacity, pausing new development projects and land acquisitions, and reviewing whether selected development sites should be sold. Its revised capital expenditure forecast is lower, although the business still faces a substantial investment programme.

Liquidity provides some breathing room. The A$8.675 billion total includes A$1.275 billion in cash and A$7.4 billion in undrawn debt facilities and hybrid securities. However, available funding should not be confused with cash generated by operations, particularly while construction spending remains elevated.

What could change the outlook?

NEXTDC has also announced board renewal following the setback, with its chairman intending to retire once a successor is appointed. Chief executive Craig Scroggie has agreed to forgo his FY27 bonus opportunities, adding accountability as management works to restore confidence.

The next major test is whether electricity supply can be restored on a reliable timetable and whether the affected contracts can ultimately generate revenue without significant additional costs. Planning decisions for further stages of M3 also remain outstanding.

Insight: Is the sell-off creating an opportunity?

Our assessment is that NEXTDC retains an attractive position in digital infrastructure, but the recent decline does not, by itself, establish that the shares are undervalued. The critical issue is whether delayed revenue can be recovered without damaging customer relationships, increasing project costs or weakening future cash generation. We are also concerned that a capital-intensive business could face prolonged uncertainty if power and planning approvals remain outside its control. Evidence of reliable delivery and disciplined spending would strengthen the outlook.

The next milestone matters more than the rebound

NEXTDC expects to provide an initial update on its capital expenditure review at its annual general meeting on 20 November 2026. The half-year results may also clarify potential changes to the valuation of its investment properties.

We will be looking for measurable progress on power delivery, revised project timelines and the conversion of contracted capacity into revenue. Can NEXTDC turn its substantial liquidity and customer demand into dependable financial performance, or will infrastructure constraints continue to delay the growth that underpins its business case?

Danny Aad

Danny Aad

(Technology & Biotechnology Specialist | StockScope)

Danny Aad is an experienced technology executive with a distinguished career spanning more than three decades, including senior leadership positions as Chief Technology Officer (CTO) across the technology and biotechnology sectors. With extensive expertise in technology strategy, digital innovation and the evolving biotechnology landscape, Danny brings a wealth of industry knowledge and technical insight to his analysis of emerging technologies, corporate developments and investment opportunities.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...